Industry news focusing on the people and organizations who work in the clinical trials profession.
Asli Memisoglu
As the new director of biostatistics and data management for WorldCare Clinical (Boston, MA), Asli Memisoglu, PhD, will oversee the development of image analysis performance metrics, statistical design, and database management between the company's project managers, sponsors, and independent reviewers.
Jack Polidoro
Joining BASi (West Lafayette, IN) in December of 2008, Jack Polidoro, PhD, will now focus on the company's Evansville, Indiana, operations, where he will work with the toxicology lab's business development efforts.
Robert Fetterman
The executive team of WorldCare Clinical (Boston, MA) has gained Robert Fetterman as associate director of imaging services, where he will leverage the clinical core laboratory and imaging experience of the company to extend the function of its imaging transmission platform, WorldPro.
Antal Hajos
In his new role as managing director and chief executive officer of Europe for Ecron Acunova (Frankfurt, Germany), Antal Hajos, PhD, will have overall responsibility for all business, strategic, and operational aspects of the European operations.
Trio Clinical Research (Durham, NC) has expanded its team with the additions of Kurt Mussina as the new senior vice president of business development and Jim Calvin as the senior vice president of clinical services.
Set to lead core business functions are three new additions to the Lantheus Medical Imaging (Billerica, MA) team: Mary Taylor as vice president of regulatory affairs, Ildia Gonzalez Ojeda as senior director of quality operations, and Jeffrey Young as global controller.
Three managers have been appointed at Synexus' (Manchester, UK) UK headquarters, including Noreen Younis as feasibility manager, Joanne Lee, as contract center manager, and Michael Fort as Synexus chief executive.
Behind the Buzz: Why Clinical Research Leaders Flock to SCOPE Summit
February 7th 2025In this episode, we meet with Micah Lieberman, Executive Conference Director for SCOPE Summit (Summit for Clinical Ops Executives) at Cambridge Innovation Institute. We will dive deep into the critical role of collaboration within the clinical research ecosystem. How do we bring together diverse stakeholders—sponsors, CROs, clinical trial tech innovators, suppliers, patients, sites, advocacy organizations, investors, and non-profits—to share best practices in trial design, program planning, innovation, and clinical operations? We’ll explore why it’s vital for thought leaders to step beyond their own organizations and learn from others, exchanging ideas that drive advancements in clinical research. Additionally, we’ll discuss the pivotal role of scientific conferences like SCOPE Summit in fostering these essential connections and collaborations, helping shape the future of clinical trials. Join us as we uncover how collective wisdom and cross-industry partnerships are transforming the landscape of clinical research.
Phase III Trial Data Show Subcutaneous Pembrolizumab as Noninferior to IV Keytruda
March 31st 2025Subcutaneous administration of pembrolizumab with chemotherapy demonstrated a nearly 50% reduction in patient chair and treatment room time while maintaining efficacy and safety endpoints compared to intravenous Keytruda.
Reaching Diverse Patient Populations With Personalized Treatment Methods
January 20th 2025Daejin Abidoye, head of solid tumors, oncology development, AbbVie, discusses a number of topics around diversity in clinical research including industry’s greatest challenges in reaching diverse patient populations, personalized treatment methods, recruitment strategies, and more.